Trademarkia Logo

Canada

C$
AAVANTIBIO
REGISTERED

on 14 Mar 2024

Last Applicant/ Owned by

AAVANTIBIO INC.

18th Floor245 First StreetCambridge MA 02142

US

Serial Number

2203529 filed on 5th Jul 2022

Registration Number

TMA1225470 registered on 14th Mar 2024

Registration expiry Date

5th Jul 2032

Correspondent Address

STEWART MCKELVEY

600-1741 Lower Water StreetHalifax

NOVA SCOTIA

CA

B3J3P6

AAVANTIBIO

Trademark usage description

biological treatments, namely, biological preparations for use in the clinical, medicinal, and therapeutic treatment of friedreich's ataxia, genetic d Read More

Classification Information


Class [005]
Biological treatments, namely, biological preparations for use in the clinical, medicinal, and therapeutic treatment of Friedreich's Ataxia, genetic disorders, genetic diseases, and rare diseases; biopharmaceutical reagents for medical use, for use in gene therapy for the treatment of Friedreich's Ataxia, genetic disorders, genetic diseases, and rare diseases; biopharmaceutical preparations for human use for the treatment of Friedreich's Ataxia, genetic disorders, genetic diseases, and rare diseases.


Classification kind code

11

Mark Details


Serial Number

2203529

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 26
on 1st Dec 2023
Approved
Submitted for opposition 27
on 1st Dec 2023
Approval Notice Sent
Submitted for opposition 22
on 27th Nov 2023
Search Recorded
Submitted for opposition 256
on 12th Jun 2023
Notification of Possible Opposition Sent
Submitted for opposition 48
on 31st Oct 2022
Agent Changed
Submitted for opposition 257
on 11th Aug 2022
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 10th Aug 2022
Formalized
Submitted for opposition 1
on 10th Aug 2022
Created
Submitted for opposition 228
on 5th Jul 2022
International Registration
Submitted for opposition 30
on 5th Jul 2022
Filed